Diabetes

News

Novo begins R&D tie-up with AI biotech e-Therapeutics

Novo Nordisk has signed a deal with UK biotech e-Therapeutics to use its AI-based drug discovery technology to find new therapies for type 2 diabetes.

News

Novo Nordisk's diabetes pill clears cardiac safety hurdle

Novo Nordisk is set to file its daily semaglutide type 2 diabetes pill after it cleared a phase 3 trial assessing its cardiac safety, with results showing it also reduced risk of cardiovasc

News

US regulator grants fast review for AZ ovarian cancer drug

The US Food and Drug Administration (FDA) has granted AstraZeneca priority review for its ovarian cancer drug Lynparza – and the company has also revealed positive results for its diabetes

News

Diabetes drugs cost NHS more than £1bn a year

Diabetes prescriptions are costing the NHS in England more than £1 billion a year, driven by an increase in the number of patients rather than rising drug costs.

News

Amazon sells exclusive diabetes and hypertension devices

Amazon has launched an exclusive range of medical devices to help people manage their diabetes and hypertension at home.

News

Sensyne's gestational diabetes AI app launches on the NHS

Artificial intelligence company Sensyne Health has launched a new app that helps women manage gestational diabetes, and five NHS hospitals have already signed up.

Novo begins R&D tie-up with AI biotech e-Therapeutics

Novo Nordisk's diabetes pill clears cardiac safety hurdle

US regulator grants fast review for AZ ovarian cancer drug

Diabetes drugs cost NHS more than £1bn a year

Amazon sells exclusive diabetes and hypertension devices

Sensyne's gestational diabetes AI app launches on the NHS

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Diabetes

Editor's Picks